BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26840075)

  • 1. Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
    Huang WC; Ke MW; Cheng CC; Chiou SH; Wann SR; Shu CW; Chiou KR; Tseng CJ; Pan HW; Mar GY; Liu CP
    PLoS One; 2016; 11(2):e0142476. PubMed ID: 26840075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
    Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
    Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
    Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
    Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
    Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways.
    Yu M; Wu X; Wang J; He M; Han H; Hu S; Xu J; Yang M; Tan Q; Wang Y; Wang H; Xie W; Kong H
    Int J Med Sci; 2022; 19(4):681-694. PubMed ID: 35582418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
    Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB.
    Bai Y; Li ZX; Wang HL; Lian GC; Wang Y
    Int J Mol Med; 2017 Jul; 40(1):155-163. PubMed ID: 28560440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
    Zhu R; Bi L; Kong H; Xie W; Hong Y; Wang H
    Int J Clin Exp Pathol; 2015; 8(10):12169-76. PubMed ID: 26722401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension.
    Huang J; Kaminski PM; Edwards JG; Yeh A; Wolin MS; Frishman WH; Gewitz MH; Mathew R
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1250-9. PubMed ID: 18390833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
    Luan Y; Chao S; Ju ZY; Wang J; Xue X; Qi TG; Cheng GH; Kong F
    Int Immunopharmacol; 2015 May; 26(1):188-93. PubMed ID: 25601497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension.
    Xi X; Liu S; Shi H; Yang M; Qi Y; Wang J; Du J
    Cardiovasc Toxicol; 2014 Dec; 14(4):368-78. PubMed ID: 24825325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats].
    Li XW; Guo B; Shen YY; Yang JR
    Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.